Animal models of COPD-current status of an evolving field

Chronic Obstructive Pulmonary Disease Exacerbations

Volumn , Issue , 2008, Pages 169-190

  Christensen, Paul J ^a   Fields, W Bradley ^a   Freeman, Christine M ^a   Curtis, Jeffrey L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955758272     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (145)

1. Shapiro SD. Mighty mice: transgenic technology “knocks out” questions of matrix metalloproteinase function. Matrix Biol 1997; 15(8-9): 527-533.
2. Canning BJ. Modeling asthma and COPD in animals: a pointless exercise? Curr Opin Pharmacol 2003; 3(3): 244-250.
3. Karlinsky JB, Snider GL. Animal models of emphysema. Am Rev Respir Dis 1978; 117(6): 1109-1133.
4. Reid LM. Needs for animal models of human diseases of the respiratory system. Am J Pathol 1980; 101(3 suppl): S89-S101.
5. Thomas RD, Vigerstad TJ. Use of laboratory animal models in investigating emphysema and cigarette smoking in humans. Regul Toxicol Pharmacol 1989; 10(3): 264-271.
6. Campbell EJ. Animal models of emphysema: the next generations. J Clin Invest 2000; 106(12): 1445-1446.
7. Nikula KJ, Green FH. Animal models of chronic bronchitis and their relevance to studies of particle-induced disease. Inhal Toxicol 2000; 12(suppl 4): 123-153.
8. Dawkins PA, Stockley RA. Animal models of chronic obstructive pulmonary disease. Thorax 2001; 56(12): 972-977.
9. Fehrenbach H. Animal models of chronic obstructive pulmonary disease: some critical remarks. Pathobiology 2002; 70(5): 277-283.
10. Tuder RM, McGrath S, Neptune E. The pathobiological mechanisms of emphysema models: what do they have in common? Pulm Pharmacol Ther 2003; 16(2): 67-78.
11. Vlahos R, Bozinovski S, Gualano RC, et al. Modelling COPD in mice. Pulm Pharmacol Ther 2006; 19(1): 12-17.
12. Mahadeva R, Shapiro SD. Chronic obstructive pulmonary disease-3: experimental animal models of pulmonary emphysema. Thorax 2002; 57(10): 908-914.
13. Brusselle GG, Bracke KR, Maes T, et al. Murine models of COPD. Pulm Pharmacol Ther 2006; 19(3): 155-165.
14. Pauluhn J, Mohr U. Experimental approaches to evaluate respiratory allergy in animal models. Exp Toxicol Pathol 2005; 56(4-5): 203-234.
15. Corry DB, Irvin CG. Promise and pitfalls in animal-based asthma research: building a better mousetrap. Immunol Res 2006; 35(3): 279-294.
16. Shapiro SD. Animal models of asthma: pro: allergic avoidance of animal (model[s]) is not an option. Am J Respir Crit Care Med 2006; 174(11): 1171-1173.
17. Wenzel S, Holgate ST. The mouse trap: it still yields few answers in asthma. Am J Respir Crit Care Med 2006; 174(11): 1173-1176.
18. Zosky GR, Sly PD. Animal models of asthma. Clin Exp Allergy 2007; 37(7): 973-988.
19. Herszberg B, Ramos-Barbon D, Tamaoka M, et al. Heaves, an asthma-like equine disease, involves airway smooth muscle remodeling. J Allergy Clin Immunol 2006; 118(2): 382-388.
20. Couetil LL, Hoffman AM, Hodgson J, et al. Inflammatory airway disease of horses. J Vet Intern Med 2007; 21(2): 356-361.
21. Shapiro SD. Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease. Eur Respir J 2007; 29(2): 375-378.
22. Hautamaki RD, Kobayashi DK, Senior RM, et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277(5334): 2002-2004.
23. March TH, Barr EB, Finch GL, et al. Cigarette smoke exposure produces more evidence of emphysema in B6C3F1 mice than in F344 rats. Toxicol Sci 1999; 51(2): 289-299.
24. D’Hulst AI, Vermaelen KY, Brusselle GG, et al. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005; 26(2): 204-213.
25. Edwards K, Braun KM, Evans G, et al. Mainstream and sidestream cigarette smoke condensates suppress macrophage responsiveness to interferon gamma. Hum Exp Toxicol 1999; 18(4): 233-240.
26. Sullivan S. The Reference and Research Cigarette Series. Lexington, KY: University of Kentucky Printing Services, 1984.
27. Roemer E, Stabbert R, Rustemeier K, et al. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 2004; 195(1): 31-52.
28. Hodge-Bell KC, Lee KM, Renne RA, et al. Pulmonary inflammation in mice exposed to mainstream cigarette smoke. Inhal Toxicol 2007, 19(4), 361-376.
29. Castro P, Legora-Machado A, Cardilo-Reis L, et al. Inhibition of interleukin-1beta reduces mouse lung inflammation induced by exposure to cigarette smoke. Eur J Pharmacol 2004; 498 (1-3): 279-286.
30. Vlahos R, Bozinovski S, Jones JE, et al. Differential protease, innate immunity, and NFkappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 2006; 290(5): L931-L945.
31. Simani AS, Inoue S, Hogg JC. Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke. Lab Invest 1974; 31(1): 75-81.
32. Sekhon HS, Wright JL, Churg A. Cigarette smoke causes rapid cell proliferation in small airways and associated pulmonary arteries. Am J Physiol 1994; 267(5 pt 1): L557-L563.
33. March TH, Wilder JA, Esparza DC, et al. Modulators of cigarette smoke-induced pulmonary emphysema in A/J mice. Toxicol Sci 2006; 92(2): 545-559.
34. Maes T, Bracke KR, Vermaelen KY, et al. Murine TLR4 Is Implicated in cigarette smokeinduced pulmonary inflammation. Int Arch Allergy Immunol 2006; 141(4): 354-368.
35. Houghton AM, Quintero PA, Perkins DL, et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006; 116(3): 753-759.
36. Elliott MK, Sisson JH, Wyatt TA. Effects of cigarette smoke and alcohol on ciliated tracheal epithelium and inflammatory cell recruitment. Am J Respir Cell Mol Biol 2007; 36(4): 452-459.
37. Thatcher TH, McHugh NA, Egan RW, et al. Role of CXCR2 in cigarette smoke-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol 2005; 289(2): L322-L328.
38. Valenca SS, Castro P, Pimenta WA, et al. Light cigarette smoke-induced emphysema and NFkappaB activation in mouse lung. Int J Exp Pathol 2006; 87(5): 373-381.
39. Guerassimov A, Hoshino Y, Takubo Y, et al. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am J Respir Crit Care Med 2004; 170(9): 974-980.
40. Bartalesi B, Cavarra E, Fineschi S, et al. Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur Respir J 2005; 25(1): 15-22.
41. Leclerc O, Lagente V, Planquois JM, et al. Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice. Eur Respir J 2006; 27(6): 1102-1109.
42. Martorana PA, Beume R, Lucattelli M, et al. Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. Am J Respir Crit Care Med 2005; 172(7): 848-853.
43. Churg A, Dai J, Tai H, et al. Tumor necrosis factor-alpha is central to acute cigarette smokeinduced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002; 166(6): 849-854.
44. Dhami R, Gilks B, Xie C, et al. Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha1-antitrypsin. Am J Respir Cell Mol Biol 2000; 22(2): 244-252.
45. Churg A, Wang RD, Tai H, et al. Macrophage metalloelastase mediates acute cigarette smokeinduced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med 2003; 167(8): 1083-1089.
46. Thomas WR, Holt PG, Keast D. Cigarette smoke and phagocyte function: effect of chronic exposure in vivo and acute exposure in vitro. Infect Immun 1978; 20(2): 468-475.
47. D’Hulst AI, Maes T, Bracke KR, et al. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? Respir Res 2005; 6: 147.
48. Bracke KR, D’Hulst AI, Maes T, et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 2006; 177(7): 4350-4359.
49. Bracke KR, D’Hulst AI, Maes T, et al. Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice. Clin Exp Allergy 2007; 37(10): 1467-1479.
50. Robbins CS, Dawe DE, Goncharova SI, et al. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004; 30(2): 202-211.
51. Drannik AG, Pouladi MA, Robbins CS, et al. Impact of cigarette smoke on clearance and Inflammation following Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2004; 170(11): 1164-1171.
52. Robbins CS, Bauer CM, Vujicic N, et al. Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am J Respir Crit Care Med 2006; 174(12): 1342-1351.
53. Mannino D, Homa D, Akinbami L, et al. Chronic obstructive pulmonary disease surveillance-United States, 1971 to 2000. MMWR 2002; 51(SS-6): 1-16.
54. Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med 2004; 25(2): 331-341.
55. Gan WQ, Man SFP, Postma DS, et al. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and metaanalysis. Respir Res 2006; 7: 52.
56. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999; 54(12): 1119-1138.
57. Tan KS, McFarlane LC, Lipworth BJ. Paradoxical down-regulation and desensitization of beta2- adrenoceptors by exogenous progesterone in female asthmatics. Chest 1997; 111(4): 847-851.
58. Martinez FJ, Curtis JL, Sciurba F, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007; 176(3): 243-252.
59. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317(21): 1309-1314.
60. Mitchell VL, Gershwin LJ. Progesterone and environmental tobacco smoke act synergistically to exacerbate the development of allergic asthma in a mouse model. Clin Exp Allerg 2007; 37(2): 276-286.
61. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343(4): 269-280.
62. Thurlbeck WM. Postnatal human lung growth. Thorax 1982; 37(8): 564-571.
63. Mead J. Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis 1980; 121(2): 339-342.
64. Society. AT. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144(5): 1202-1218.
65. Tashkin DP, Altose MD, Bleecker ER, et al. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis 1992; 145(2 pt 1): 301-310.
66. Tashkin DP, Altose MD, Connett JE, et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996; 153(6 pt 1): 1802-1811.
67. Shapiro SD. Proteolysis in the lung. Eur Respir J Suppl 2003; 44: 30s-32s.
68. Churg A, Wright JL. Proteases and emphysema. Curr Opin Pulm Med 2005; 11(2): 153-159.
69. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001; 17(5): 946-953.
70. Calabrese F, Giacometti C, Beghe B, et al. Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir Res 2005; 6: 14.
71. Demedts IK, Demoor T, Bracke KR, et al. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006; 7: 53.
72. Martorana PA, van Even P, Gardi C, et al. A 16-month study of the development of genetic emphysema in tight-skin mice. Am Rev Respir Dis 1989; 139(1): 226-232.
73. Lucattelli M, Cavarra E, de Santi MM, et al. Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema. Eur Respir J 2003; 22(5): 728-734.
74. Takubo Y, Guerassimov A, Ghezzo H, et al. Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human disease. Am J Respir Crit Care Med 2002; 166(12 pt 1): 1596-1603.
75. Imura A, Tsuji Y, Murata M, et al. alpha-Klotho as a regulator of calcium homeostasis. Science 2007; 316(5831): 1615-1618.
76. Lanske B, Razzaque MS. Premature aging in klotho mutant mice: cause or consequence? Ageing Res Rev 2007; 6(1): 73-79.
77. Tsujikawa H, Kurotaki Y, Fujimori T, et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003; 17(12): 2393-2403.
78. Razzaque MS, Sitara D, Taguchi T, et al. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 2006; 20(6): 720-722.
79. Sato A, Hirai T, Imura A, et al. Morphological mechanism of the development of pulmonary emphysema in klotho mice. Proc Natl Acad Sci U S A 2007; 104(7): 2361-2365.
80. Funada Y, Nishimura Y, Yokoyama M. Imbalance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho mice. Kobe J Med Sci 2004; 50(3-4): 59-67.
81. Mori T, Ishigami A, Seyama K, et al. Senescence marker protein-30 knockout mouse as a novel murine model of senile lung. Pathol Int 2004; 54(3): 167-173.
82. Sato T, Seyama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med 2006; 174(5): 530-537.
83. Takeda T. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiol Aging 1999; 20(2): 105-110.
84. Kasagi S, Seyama K, Mori H, et al. Tomato juice prevents senescence-accelerated mouse P1 strain from developing emphysema induced by chronic exposure to tobacco smoke. Am J Physiol Lung Cell Mol Physiol 2006; 290(2): L396-L404.
85. Rangasamy T, Cho CY, Thimmulappa RK, et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004; 114(9): 1248-1259.
86. Tang K, Rossiter HB, Wagner PD, et al. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 2004; 97(4): 1559-1566.
87. Wang Z, Zheng T, Zhu Z, et al. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 2000; 192(11): 1587-1600.
88. Vuillemenot BR, Rodriguez JF, Hoyle GW. Lymphoid tissue and emphysema in the lungs of transgenic mice inducibly expressing tumor necrosis factor-alpha. Am J Respir Cell Mol Biol 2004; 30(4): 438-448.
89. Lappalainen U, Whitsett JA, Wert SE, et al. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005; 32(4): 311-318.
90. Majori M, Corradi M, Caminati A, et al. Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol 1999; 103 (3 pt 1): 458-462.
91. Saetta M, Mariani M, Panina-Bordignon P, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 165(10): 1404-1409.
92. Zheng T, Zhu Z, Wang Z, et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000; 106(9): 1081-1093.
93. Barcelo B, Pons J, Fuster A, et al. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2006; 145(3): 474-479.
94. D’Armiento J, Dalal SS, Okada Y, et al. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992; 71(6): 955-961.
95. Elias JA, Kang MJ, Crouthers K, et al. State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice. Proc Am Thorac Soc 2006; 3(6): 494-498.
96. Kuang PP, Goldstein RH. Regulation of elastin gene transcription by interleukin-1 betainduced C/EBP beta isoforms. Am J Physiol Cell Physiol 2003; 285(6): C1349-C1355.
97. Ekberg-Jansson A, Andersson B, Bake B, et al. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med 2001; 95(5): 363-373.
98. Kasahara Y, Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163(3 pt 1): 737-744.
99. Tuder RM, Petrache I, Elias JA, et al. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 2003; 28(5): 551-554.
100. Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004; 125(2): 626-632.
101. Wright JL, Churg A. Current concepts in mechanisms of emphysema. Toxicol Pathol 2007; 35(1): 111-115.
102. Zheng T, Kang MJ, Crothers K, et al. Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J Immunol 2005; 174(12): 8106-8115.
103. Nana-Sinkam SP, Lee JD, Sotto-Santiago S, et al. Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am J Respir Crit Care Med 2007; 175(7): 676-685.
104. Whitsett JA, Perl AK. Conditional control of gene expression in the respiratory epithelium: a cautionary note. Am J Respir Cell Mol Biol 2006; 34(5): 519-520.
105. Zhu Z, Zheng T, Lee CG, et al. Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. Semin Cell Dev Biol 2002; 13(2): 121-128.
106. Zhu Z, Ma B, Homer RJ, et al. Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem 2001; 276(27): 25222-25229.
107. Sisson TH, Hansen JM, Shah M, et al. Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice. Am J Respir Cell Mol Biol 2006; 34(5): 552-560.
108. Perl AK, Wert SE, Loudy DE, et al. Conditional recombination reveals distinct subsets of epithelial cells in trachea, bronchi, and alveoli. Am J Respir Cell Mol Biol 2005; 33(5): 455-462.
109. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005; 171(7): 734-742.
110. Taraseviciene-Stewart L, Douglas IS, Nana-Sinkam PS, et al. Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc Am Thorac Soc 2006; 3(8): 687-690.
111. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13(5): 567-569.
112. Omori H, Nakashima R, Otsuka N, et al. Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence, and correlation with smoking habits and pulmonary function in Japanese male subjects. Respirology 2006; 11(2): 205-210.
113. Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62(9): 835-841.
114. Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 2003; 28(5): 555-562.
115. Petrache I, Natarajan V, Zhen L, et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005; 11(5): 491-498.
116. Petrache I, Fijalkowska I, Zhen L, et al. A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 2006; 173(11): 1222-1228.
117. Foxwell AR, Kyd JM, Cripps AW. Characteristics of the immunological response in the clearance of non-typeable Haemophilus influenzae from the lung. Immunol Cell Biol 1998; 76(4): 323-331.
118. Foxwell AR, Kyd JM, Cripps AW. Kinetics of inflammatory cytokines in the clearance of nontypeable Haemophilus influenzae from the lung. Immunol Cell Biol 1998; 76(6): 556-559.
119. Wang X, Moser C, Louboutin JP, et al. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol 2002; 168(2): 810-815.
120. Moser C, Weiner DJ, Lysenko E, et al. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 2002; 70(6): 3068-3072.
121. Finch GL, Lundgren DL, Barr EB, et al. Chronic cigarette smoke exposure increases the pulmonary retention and radiation dose of 239Pu inhaled as 239PuO2 by F344 rats. Health Phys 1998; 75(6): 597-609.
122. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106(11): 1311-1319.
123. Tuder RM, Zhen L, Cho CY, et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003; 29(1): 88-97.
124. Tesson L, Cozzi J, Menoret S, et al. Transgenic modifications of the rat genome. Transgenic Res 2005; 14(5): 531-546.
125. Melo EO, Canavessi AM, Franco MM, et al. Animal transgenesis: state of the art and applications. J Appl Genet 2007; 48(1): 47-61.
126. Wright JL, Churg A. A model of tobacco smoke-induced airflow obstruction in the guinea pig. Chest 2002; 121(5 suppl): 188S-191S.
127. Kubo S, Kobayashi M, Masunaga Y, et al. Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs. Eur Respir J 2005; 26(6): 993-1001.
128. Matsuse T, Hayashi S, Kuwano K, et al. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146(1): 177-184.
129. Elliott WM, Hayashi S, Hogg JC. Immunodetection of adenoviral E1A proteins in human lung tissue. Am J Respir Cell Mol Biol 1995; 12(6): 642-648.
130. Vitalis TZ, Kern I, Croome A, et al. The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. Eur Respir J 1998; 11(3): 664-669.
131. Meshi B, Vitalis TZ, Ionescu D, et al. Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002; 26(1): 52-57.
132. Milot J, Meshi B, Taher Shabani Rad M, et al. The effect of smoking cessation and steroid treatment on emphysema in guinea pigs. Respir Med 2007; 101(11): 2327-2335.
133. Olsson LE, Lindahl M, Onnervik PO, et al. Measurement of MR signal and T2* in lung to characterize a tight skin mouse model of emphysema using single-point imaging. J Magn Reson Imaging 2007; 25(3): 488-494.
134. Dransfield MT, Washko GR, Foreman MG, et al. Gender differences in the severity of CT emphysema in COPD. Chest 2007; 132(2): 464-470.
135. Fan VS, Ramsey SD, Giardino ND, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007; 167(21): 2345-2353.
136. Han MK, Postma D, Mannino D, et al. Gender and COPD: why it matters. Am J Respir Crit Care Med 2007; 176(12): 1179-1184.
137. Card JW, Carey MA, Bradbury JA, et al. Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation. J Immunol 2006; 177(1): 621-630.
138. Mercer JF, Grimes A, Ambrosini L, et al. Mutations in the murine homologue of the Menkes gene in dappled and blotchy mice. Nat Genet 1994; 6(4): 374-378.
139. Martorana PA, Brand T, Gardi C, et al. The pallid mous. A model of genetic alpha 1-antitrypsin deficiency. Lab Invest 1993; 68(2): 233-241.
140. Huang L, Kuo YM, Gitschier J. The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency. Nat Genet 1999; 23(3): 329-332.
141. Szapiel SV, Fulmer JD, Hunninghake GW, et al. Hereditary emphysema in the tight-skin (Tsk/+) mouse. Am Rev Respir Dis 1981; 123(6): 680-685.
142. Keil M, Lungarella G, Cavarra E, et al. A scanning electron microscopic investigation of genetic emphysema in tight-skin, pallid, and beige mice, three different C57 BL/6J mutants. Lab Invest 1996; 74(2): 353-362.
143. Colarossi C, Chen Y, Obata H, et al. Lung alveolar septation defects in Ltbp-3-null mice. Am J Pathol 2005; 167(2): 419-428.
144. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390(6655): 45-51.
145. Suga T, Kurabayashi M, Sando Y, et al. Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. Am J Respir Cell Mol Biol 2000; 22(1): 26-33.